[HTML][HTML] Five-day antibiotic treatment for community-acquired bacterial pneumonia: A systematic review and meta-analysis of randomized controlled trials

SH Lan, CC Lai, SP Chang, LC Lu, SH Hung… - Journal of Global …, 2020 - Elsevier
Objectives This systematic review and meta-analysis of randomized controlled trials (RCTs)
investigated whether the clinical efficacy of a 5-day antibiotic course is comparable to that of …

Risk of Multidrug-Resistant Pathogens in Severe Community-Acquired Pneumonia

E Campaña-Duel, M Camprubí-Rimblas… - … in Respiratory and …, 2024 - thieme-connect.com
Severe community-acquired pneumonia (SCAP) is difficult to treat when caused by difficult-
to-treat (DTR) pathogens because of limited treatment options and poorer clinical outcomes …

Ceftobiprole and pneumonia in adults admitted to the emergency department is it time to assess a new therapeutic algorithm?

M Crapis, S Venturini, P Della Siega… - Journal of …, 2021 - Taylor & Francis
Objective Ceftobiprole is an advance generation cephalosporin which has broad-spectrum
bacterial activity (both against Gram-positive and negative pathogens) and was approved for …

Community-acquired pneumonia: current data

Z Tsilogianni, K Grapatsas, L Vasileios… - Annals of Research …, 2017 - arh.amegroups.org
A new term was introduced in 2005 from the American Thoracic Society and Infectious
Diseases Society of America (ATS/IDSA): health-care associated pneumonia (HCAP) which …

Emerging resistance of Gram negative pathogens in community-acquired pneumonia

F Amati, MI Restrepo - Seminars in Respiratory and Critical …, 2020 - thieme-connect.com
In recent decades, there has been a growing interest about the role of gram negative
bacteria in community-acquired pneumonia (CAP), especially Pseudomonas aeruginosa …

An update on the pharmacotherapeutic management of lower respiratory tract infections

M Cazzola, P Rogliani, S Aliberti, F Blasi… - Expert Opinion on …, 2017 - Taylor & Francis
Introduction: Our knowledge about lower respiratory tract infections (LRTIs) has improved
substantially in the last years, but the management of respiratory infections is still a …

The past decade in bench research into pulmonary infectious diseases: W hat do clinicians need to know?

S Finch, HR Keir, AJ Dicker, JD Chalmers - Respirology, 2017 - Wiley Online Library
Respiratory infections are primarily treated with antibiotics, drugs that are mostly
inexpensive and have been widely available since the 1940s and 1950s. Nevertheless …

[HTML][HTML] Внебольничная пневмония. Диагностика, подходы к лечению

АА Андержанова, ЮА Мелёшкина - Клиницист, 2019 - cyberleninka.ru
В статье представлены современные данные о распространенности и этиологии
внебольничной пневмонии, показан вклад каждого из возможных возбудителей в …

[HTML][HTML] Year in review 2013: critical care - respiratory infections

GB Nair, MS Niederman - Critical Care, 2014 - Springer
Infectious complications, particularly in the respiratory tract of critically ill patients, are related
to increased mortality. Severe infection is part of a multiple system illness and female …

Validation of a community-acquired pneumonia score to improve empiric antibiotic selection at an academic medical center

MB Oliver, K Fong, L Certain, ES Spivak… - Antimicrobial Agents …, 2021 - Am Soc Microbiol
ABSTRACT The 2019 American Thoracic Society and the Infectious Diseases Society of
America community-acquired pneumonia (CAP) guidelines recommend that drug-resistant …